SI-BONE INC (SIBN)

Company Profile

SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 357 full-time employees. The company went IPO on 2018-10-17. The firm is engaged in solving musculoskeletal disorders of the sacropelvic anatomy. The firm's products include a series of patented titanium implants and the instruments used to implant them. The company offers iFuse, iFuse-3D, and iFuse-TORQ implant systems. iFuse is a machined triangular titanium implant that has a triangular cross-section that resists twisting or rotation of the implant. iFuse-3D implants are used for the fusion of the sacroiliac joint in conjunction with multi-level spinal fusion procedures to provide further stabilization and immobilization of the sacroiliac joint. iFuse-TORQ is a line of three-dimensional (3D)-printed threaded implants designed for use in pelvic trauma, as well as applications in sacroiliac joint dysfunction and degeneration. The firm also holds patents for the method of placing the implant across the sacroiliac joint, as well as other parts of the spine and pelvis.

Company Info

SI-BONE INC

471 El Camino Real, Suite 101

Santa Clara CALIFORNIA 95050

P: 14082070700

CEO: Jeffrey W. Dunn

Employees: 357

Website: https://si-bone.com/